Indeed, pharmacological inhibition of the MALT1 protease function has been reported to exert selective toxicity towards MALT1-dependent lymphomas both in vitro and in vivo using xenograft mouse models [154,155]. This evidence concerns the gene MALT1 and lymphoma.